Assessing the potential for CTUM shareholders from LTC:
We know the market for sutures/staples is $4.1 Billion per year and growing. It is not unrealistic to assume LTC can capture 15% of this market in several years. That is $600 million in sales to LTC. If CSMG owns, say, 50% of LTC, then it would receive half of the earnings, on a consolidated basis. Pretax, the margin on this product should be at least 50% of sales, so CTUM would realize half of $300 million, or $150 mil. pretax and at least $100 mil. after tax. If CSMG has 40 mil. shs OS, then net per share = $2.50. Multiply this by a modest 20 P/E, and you get a stock price of $50. And this assumes NO value from any other technologies CSMG may come up with in the meantime. This is not at all unreasonable, or un-doable IMO.